Efficacy of etimicin combined with levofloxacin on MRSA infections in diabetic foot
-
摘要: 目的 探讨依替米星联合左氧氟沙星对糖尿病足耐甲氧西林金黄色葡萄球菌(MRSA)感染的治疗作用,并对MRSA荚膜多糖致病基因多态性进行初步研究。 方法 选取2012年10月-2014年10月期间于杭州师范大学附属医院接受治疗的糖尿病足MRSA感染患者78例,采用随机数字表法分为对照组和实验组。对照组39例,其中男性20例,女性19例,年龄30~72岁,平均年龄(47.8±18.2)岁,采用左氧氟沙星进行治疗;实验组39例,其中男性20例,女性19例,年龄28~75岁,平均年龄(49.1±19.5)岁,采用硫酸依替米星联合左氧氟沙星治疗,2组患者治疗时间均为4周,采用Wagner分级法对患者疗效进行评定,比较2组患者糖尿病足治疗有效率,并且对其致病因素荚膜多糖中致病基因进行研究。 结果 实验组临床总有效率显著高于对照组(P<0.05),在治疗后28 d,创面细菌金黄色葡萄球菌阳性率实验组显著低于对照组(P<0.05);荚膜多糖主要是通过保护细菌倍吞噬系统吞噬从而抵抗抗生素杀伤力,对患者创面细菌进行荚膜多糖基因PCR分析结果显示荚膜多糖致病基因主要以5型以及8型为主(61.5%)。 结论 依替米星联合左氧氟沙星对MRSA所致糖尿病足患者有较强的治疗作用,显著增加患者治疗有效率,其荚膜多糖基因主要是以荚膜多糖5型以及荚膜多糖8型为主。
-
关键词:
- 依替米星 /
- 耐甲氧西林金黄色葡萄球菌 /
- 糖尿病足感染 /
- 荚膜多糖 /
- 致病基因
Abstract: Objective To investigate the efficacy of etimicin combined with levofloxacinin the treatment of Methicillin-resistant Staphylococcus aureus (MRSA) infections in diabetic foot and the polymorphism of capsular polysaccharide synthesis gene. Methods A total of 78 diabetic patients with MRSA infections in the Affiliated Hospital of Hangzhou Normal University between October,2012 and October,2014 were randomly divided into control group (n=39) and experimental group (n=39).The patients of the control group,20 males and 19 females,aged 30-72 years with an average age of (47.8±18.2) years,received levofloxacin treatment;while the patients of the experimental group,20 males and 19 females,aged 28-75 years with an average age of (49.1±19.5) years,received etimicin combined with levofloxacin treatment.The course was 4 weeks in both groups.The efficacy was evaluated with Wagner grading method.The treatment efficiency was compared between the two groups,and the polymorphism of capsular polysaccharide synthesis gene was studied. Results The clinical overall response rate in the experimental was significantly higher (P<0.05) than the in the control group;On d28,the positive rate of Staphylococcus aureus infection in the wound in experimental group was significantly lower than that in the control group (P<0.05);PCR analysis showed that the type 5 and 8 capsular polysaccharide synthesis gene were mainly the disease gene (61.5%). Conclusion Etimicin combined with levofloxacin has obviously therapeutic effect on MRSA infections in diabetic foot,which will improve the effective rate.The type 5 and 8 capsular polysaccharide synthesis gene are mainly the disease gene.
点击查看大图
计量
- 文章访问数: 107
- HTML全文浏览量: 18
- PDF下载量: 0
- 被引次数: 0